Rani Therapeutics nabs $53m for robotic pill injection tech

Rani Therapeutics has raised $53 million to support manufacturing as it gears up for clinical trials of its robotic pill technology.

New investors like GeneScience Pharmaceuticals and Shire (NSDQ:SHPG) joined existing investors like Alphabet’s GV, Novartis (NYSE:NVS) and AstraZeneca (NYSE:AZN).

Get the full story at our sister site, Drug Delivery Business News.

The post Rani Therapeutics nabs $53m for robotic pill injection tech appeared first on MassDevice.

from MassDevice http://ift.tt/2H1mxHh